Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

NCT00163748 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non-Hodgkin's Lymphoma
Hodgkin's Disease

Interventions

DRUG: gemcitabine, vinorelbine

Sponsor

Bayside Health